最後更新
成分股列表
復華製藥債(00759B) 成分股。透過此分析ETF所持有的個股有哪些，並可進一步分析個股的合理價與價值區間。
| 排名 | 名稱 | 比例 | 其他持股的ETF | |
|---|---|---|---|---|
| 1 | PFE 5.3 05/19/5 | 3.57% | ||
| 2 | ABBV 4 1/4 11/2 | 3.33% | ||
| 3 | AMGN 5 3/4 03/0 | 2.94% | ||
| 4 | AMGN 4.663 06/1 | 2.56% | ||
| 5 | PFE 5.34 05/19/ | 2.38% | ||
| 6 | AMGN 5.65 03/02 | 2.23% | ||
| 7 | BMY 4 1/4 10/26 | 2.16% | ||
| 8 | ABBV 4.7 05/14/ | 1.96% | ||
| 9 | ABBV 4.45 05/14 | 1.63% | ||
| 10 | ABBV 4.4 11/06/ | 1.59% | ||
| 11 | GILD 4 3/4 03/0 | 1.59% | ||
| 12 | NOVNVX 4.4 05/0 | 1.56% | ||
| 13 | JNJ 3.7 03/01/4 | 1.54% | ||
| 14 | GILD 4.8 04/01/ | 1.53% | ||
| 15 | ABBV 4 7/8 11/1 | 1.51% | ||
| 16 | AMGN 3 3/8 02/2 | 1.48% | ||
| 17 | AMGN 4.4 05/01/ | 1.41% | ||
| 18 | GILD 4.15 03/01 | 1.31% | ||
| 19 | PFE 5.11 05/19/ | 1.26% | ||
| 20 | MRK 3.7 02/10/4 | 1.22% | ||
| 21 | VTRS 4 06/22/50 | 1.21% | ||
| 22 | TACHEM 3.175 07 | 1.2% | ||
| 23 | BMY 3.7 03/15/5 | 1.17% | ||
| 24 | MRK 4 03/07/49 | 1.15% | ||
| 25 | AMGN 4.4 02/22/ | 1.14% | ||
| 26 | AMGN 4.563 06/1 | 1.12% | ||
| 27 | PFE 4.4 05/15/4 | 1.09% | ||
| 28 | MRK 4.15 05/18/ | 1.05% | ||
| 29 | AMGN 4 7/8 03/0 | 1.05% | ||
| 30 | AZN 4 09/18/42 | 1.03% | ||
| 31 | GILD 4 1/2 02/0 | 1.03% | ||
| 32 | PFE 4.2 09/15/4 | 1.02% | ||
| 33 | NOVNVX 4 11/20/ | 1.01% | ||
| 34 | PFE 4 03/15/49 | 0.99% | ||
| 35 | PFE 4 1/8 12/15 | 0.97% | ||
| 36 | BMY 4.35 11/15/ | 0.97% | ||
| 37 | ZTS 4.7 02/01/4 | 0.96% | ||
| 38 | GILD 5.65 12/01 | 0.96% | ||
| 39 | BMY 3.55 03/15/ | 0.94% | ||
| 40 | GILD 2.8 10/01/ | 0.91% | ||
| 41 | NOVNVX 2 3/4 08 | 0.87% | ||
| 42 | PFE 2.7 05/28/5 | 0.85% | ||
| 43 | RPRX 3.55 09/02 | 0.81% | ||
| 44 | AZN 4 3/8 08/17 | 0.79% | ||
| 45 | LLY 3.95 03/15/ | 0.79% | ||
| 46 | AMGN 3 01/15/52 | 0.79% | ||
| 47 | BIIB 3.15 05/01 | 0.78% | ||
| 48 | JNJ 3 3/4 03/03 | 0.77% | ||
| 49 | AMGN 5.15 11/15 | 0.77% | ||
| 50 | MRK 2 3/4 12/10 | 0.76% | ||
| 51 | ABBV 4 3/4 03/1 | 0.74% | ||
| 52 | VTRS 5.2 04/15/ | 0.73% | ||
| 53 | AMGN 2.77 09/01 | 0.73% | ||
| 54 | BMY 4.55 02/20/ | 0.72% | ||
| 55 | JNJ 3 1/2 01/15 | 0.72% | ||
| 56 | VTRS 3.85 06/22 | 0.7% | ||
| 57 | VTRS 5 1/4 06/1 | 0.69% | ||
| 58 | PFE 2.55 05/28/ | 0.67% | ||
| 59 | BMY 5 08/15/45 | 0.67% | ||
| 60 | LLY 4 7/8 02/27 | 0.67% | ||
| 61 | MRK 2.9 12/10/6 | 0.66% | ||
| 62 | BIIB 5.2 09/15/ | 0.66% | ||
| 63 | AMGN 4.2 02/22/ | 0.66% | ||
| 64 | BMY 6.4 11/15/6 | 0.66% | ||
| 65 | BMY 6 1/4 11/15 | 0.65% | ||
| 66 | BMY 4 5/8 05/15 | 0.64% | ||
| 67 | AMGN 4.95 10/01 | 0.64% | ||
| 68 | AZN 4 3/8 11/16 | 0.63% | ||
| 69 | TACHEM 3 3/8 07 | 0.63% | ||
| 70 | GILD 5.55 10/15 | 0.61% | ||
| 71 | ABBV 5.4 03/15/ | 0.61% | ||
| 72 | ABBV 5 1/2 03/1 | 0.61% | ||
| 73 | ABBV 5.35 03/15 | 0.6% | ||
| 74 | BMY 5.55 02/22/ | 0.59% | ||
| 75 | BMY 5.65 02/22/ | 0.59% | ||
| 76 | RPRX 3.35 09/02 | 0.58% | ||
| 77 | AMGN 5.6 03/02/ | 0.58% | ||
| 78 | LLY 2 1/4 05/15 | 0.57% | ||
| 79 | LLY 5 02/09/54 | 0.57% | ||
| 80 | MRK 5 05/17/53 | 0.57% | ||
| 81 | LLY 4.95 02/27/ | 0.56% | ||
| 82 | ABBV 4.85 06/15 | 0.55% | ||
| 83 | TACHEM 3.025 07 | 0.52% | ||
| 84 | GSK 4.2 03/18/4 | 0.52% | ||
| 85 | VTRS 5.4 11/29/ | 0.52% | ||
| 86 | LLY 4.15 03/15/ | 0.5% | ||
| 87 | LLY 2 1/2 09/15 | 0.49% | ||
| 88 | BMY 2.35 11/13/ | 0.48% | ||
| 89 | JNJ 2.1 09/01/4 | 0.48% | ||
| 90 | ZTS 3.95 09/12/ | 0.48% | ||
| 91 | BMY 3.9 03/15/6 | 0.45% | ||
| 92 | BMY 3 1/4 08/01 | 0.45% | ||
| 93 | BMY 2.55 11/13/ | 0.43% | ||
| 94 | BIIB 3 1/4 02/1 | 0.43% | ||
| 95 | MRK 2.45 06/24/ | 0.43% | ||
| 96 | PFE 4.3 06/15/4 | 0.42% | ||
| 97 | AMGN 2.8 08/15/ | 0.42% | ||
| 98 | MRK 2.35 06/24/ | 0.41% | ||
| 99 | AZN 3 05/28/51 | 0.37% | ||
| 100 | JNJ 2 1/4 09/01 | 0.36% | ||
| 101 | JNJ 2.45 09/01/ | 0.35% | ||
| 102 | ZTS 3 05/15/50 | 0.32% | ||
| 103 | MRK 5.15 05/17/ | 0.29% | ||
| 104 | RPRX 3.3 09/02/ | 0.26% | ||
| 105 | JNJ 4 1/2 12/05 | 0.25% | ||
| 106 | REGN 2.8 09/15/ | 0.23% | ||
| 107 | TACHEM 5 1/4 06 | 0.23% | ||
| 108 | AZN 2 1/8 08/06 | 0.2% | ||
| 109 | NOVNVX 3.7 09/2 | 0.2% | ||
| 110 | MRK 3.6 09/15/4 | 0.19% | ||
| 111 | LLY 5.1 02/09/6 | 0.12% | ||
| 112 | MRK 4.9 05/17/4 | 0.11% | ||
| 113 | GILD 2.6 10/01/ | 0.08% | ||
| 114 | JNJ 4 1/2 09/01 | 0.06% |
常見問題
投資ETF常見的問題。
| 1. 復華製藥債(00759B)可以買嗎? |
| 目前大盤大盤領先指標循環為佳的條件下，買進復華製藥債(00759B)持有一季的平均年化報酬率為-3.0%，在184檔ETF中排名第117，排名位於中間。夏普指數為-0.34，在184檔ETF中排名第125，排名位於中間。 |
警語
1. 資料僅供參考，不做任何獲利保證及特定股票與點位推薦建議。
2. 資料並不完整，需要完整資料請至相關網站索取。
3. 任何股市數據分析皆存在倖存者偏差。
